BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29363935)

  • 1. Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
    Yang Y; Guo Q; Peng J; Su J; Lu X; Zhao Y; Qian Z
    J Biomed Nanotechnol; 2016 Nov; 12(11):1963-74. PubMed ID: 29363935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.
    Liang PC; Chen YC; Chiang CF; Mo LR; Wei SY; Hsieh WY; Lin WL
    Int J Nanomedicine; 2016; 11():2021-37. PubMed ID: 27274233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma.
    Shen C; Wang X; Zheng Z; Gao C; Chen X; Zhao S; Dai Z
    Int J Nanomedicine; 2019; 14():101-117. PubMed ID: 30587988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Ling Y; Wei K; Luo Y; Gao X; Zhong S
    Biomaterials; 2011 Oct; 32(29):7139-50. PubMed ID: 21726899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer.
    Gao P; Mei C; He L; Xiao Z; Chan L; Zhang D; Shi C; Chen T; Luo L
    Drug Deliv; 2018 Nov; 25(1):1811-1825. PubMed ID: 30465437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional reduction-responsive SPIO&DOX-loaded PEGylated polymeric lipid vesicles for magnetic resonance imaging-guided drug delivery.
    Wang S; Yang W; Du H; Guo F; Wang H; Chang J; Gong X; Zhang B
    Nanotechnology; 2016 Apr; 27(16):165101. PubMed ID: 26941226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Steeber DA; Gong S
    Biomaterials; 2010 Dec; 31(34):9065-73. PubMed ID: 20828811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles.
    Fan C; Gao W; Chen Z; Fan H; Li M; Deng F; Chen Z
    Int J Pharm; 2011 Feb; 404(1-2):180-90. PubMed ID: 21087660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of novel superparamagnetic Ni
    Qasim M; Asghar K; Dharmapuri G; Das D
    Nanotechnology; 2017 Sep; 28(36):365101. PubMed ID: 28675377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
    Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
    J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells.
    Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S
    Chem Biol Drug Des; 2013 Sep; 82(3):296-306. PubMed ID: 23594157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
    Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
    J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
    Lee JH; Jung MJ; Hwang YH; Lee YJ; Lee S; Lee DY; Shin H
    Biomaterials; 2012 Jun; 33(19):4861-71. PubMed ID: 22475532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
    Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
    Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
    Fu X; Wang X; Zhou S; Zhang Y
    Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
    Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y; Wei K; Zou F; Zhong S
    Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.